Nesina and Breastfeeding
Nesina (alogliptin) has been shown to pass through breast milk in rats; however, it is unknown if it would pass through breast milk in women or cause harm to a nursing infant. The manufacturer of the drug recommends that breastfeeding women use Nesina with caution. If your healthcare provider recommends this medicine while nursing, be watchful for any side effects in your child.
Nesina® (alogliptin) is a prescription medication used for the treatment of type 2 diabetes. It can be used alone or in combination with other diabetes medicines. At this time, it is unknown if Nesina passes through breast milk in humans. If you are breastfeeding or plan to start, talk to your healthcare provider before taking the medication.
Nesina has been shown to pass through the breast milk of rats. However, the drug has not been studied in breastfeeding women, so it is unknown if it passes through human breast milk or if it would harm a nursing child.
Although this lack of information is certainly frustrating, it is important to note that studies of drugs are rarely done in breastfeeding women. Doing so could expose a nursing child, who would otherwise gain no benefit from the drug, to potential harm.
Because many medicines pass through breast milk, the manufacturer of Nesina recommends it be used with caution in women who are breastfeeding. If your healthcare provider recommends Nesina while you are breastfeeding, make sure to watch your child for any side effects, and contact your child's healthcare provider if you notice anything of potential concern.
You should discuss breastfeeding and Nesina with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.